These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Some current problems in viral hepatitis. The hepatitis antigen]. Cajal N; Strati I Stud Cercet Inframicrobiol; 1970; 21(5):391-412. PubMed ID: 4323177 [No Abstract] [Full Text] [Related]
43. [A high-risk professional disease for dentists viral hepatitis B]. Matysiak M Actual Odontostomatol (Paris); 1983 Sep; (143):497-514. PubMed ID: 6660088 [No Abstract] [Full Text] [Related]
44. Hepatitis B core antigen and antibody. Hoofnagle JH; Gerety RJ; Barker LF Dev Biol Stand; 1975; 30():175-85. PubMed ID: 1204955 [TBL] [Abstract][Full Text] [Related]
45. [The delta agent. Characteristics, infectivity and clinical aspects of its infection]. Bárcena Marugan R; Boixeda de Miquel D; González Martín JA Rev Esp Enferm Apar Dig; 1985 Oct; 68(4):366-73. PubMed ID: 3909264 [No Abstract] [Full Text] [Related]
46. [The hepatitis B virus and its markers: the evolution in 25 years]. de Andrade DR; de Andrade Júnior DR Arq Gastroenterol; 1992; 29(4):119-21. PubMed ID: 1340745 [No Abstract] [Full Text] [Related]
47. [Hepatitis B virus and the delta agent: diagnostic and prognostic value of their biological markers]. Caujolle B; Mallet L; Jean F; Petite JP Rev Med Interne; 1986 Jan; 7(1):56-62. PubMed ID: 3010420 [No Abstract] [Full Text] [Related]
48. [New aspects of hepatitis B]. Markoff N Hippokrates; 1974 Nov; 45(4):521-3. PubMed ID: 4465363 [No Abstract] [Full Text] [Related]
49. [Development of acute hepatitis to chronicity]. Sapunar I Acta Gastroenterol Latinoam; 1986; 16(1):61-3. PubMed ID: 3577621 [No Abstract] [Full Text] [Related]
50. The genome of hepatitis B virus. Robinson WS Annu Rev Microbiol; 1977; 31():357-77. PubMed ID: 334041 [No Abstract] [Full Text] [Related]
51. [Comparative study of antigens specific for hepatitis B in transfected cell cultures]. Anan'eva VA; Zhilina NN; Bykovskiĭ AF; Stakhanova VM; Viazov SO Vopr Virusol; 1976; (5):545-50. PubMed ID: 1034374 [TBL] [Abstract][Full Text] [Related]
53. Viral hepatitis type B: prospects for active immunization. Krugman S Am J Med Sci; 1975; 270(2):391-3. PubMed ID: 1235480 [TBL] [Abstract][Full Text] [Related]
54. Immunization against hepatitis B. A new era in prevention. Shillitoe EJ; Steller M CDA J; 1982 Oct; 10(10):29-35. PubMed ID: 6959702 [No Abstract] [Full Text] [Related]
55. Hepatitis B virus infection. Lee WM N Engl J Med; 1997 Dec; 337(24):1733-45. PubMed ID: 9392700 [No Abstract] [Full Text] [Related]
56. The prevalence of hepatitis B viral markers in Bloemfontein anaesthetists. Vermeulen PJ; Diedericks BJ; Smith MS; de Wet JI S Afr Med J; 1987 May; 71(10):631-3. PubMed ID: 3576383 [TBL] [Abstract][Full Text] [Related]
57. Sructure and stability of the hepatitis B surface antigen. Brzosko WJ; Budkowska A; Nowoslawski A Acta Virol; 1975 Apr; 19(2):169. PubMed ID: 239567 [No Abstract] [Full Text] [Related]
58. The virus of hepatitis, type B (first of two parts). Robinson WS; Lutwick LI N Engl J Med; 1976 Nov; 295(21):1168-75. PubMed ID: 62280 [No Abstract] [Full Text] [Related]
59. [Viral hepatitis type B. Preventive measures]. Suárez M Rev Chil Pediatr; 1978; 49(1-6):102-6. PubMed ID: 756977 [No Abstract] [Full Text] [Related]
60. [Prevention of viral hepatitis--with special reference to the possibility of development of a vaccine in relation to Australia antigen]. Kaji M Nihon Rinsho; 1972 May; 30(5):1159-63. PubMed ID: 4558173 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]